Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gossec

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2015
Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experienceN Betteridge, W-H Boehncke, C Bundy, et al.
Clinical and Experimental Rheumatology|June 10, 2006
Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDsI Bettembourg-Brault, L Gossec, T Pham, et al.
Rheumatology (Oxford, England)|August 2, 2006
Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patientsC Salliot, L Gossec, A Ruyssen-Witrand, et al.
La Revue De Medecine Interne|December 4, 2012
[Whipple disease revealed by anti-TNFα therapy]L Sparsa, F Fenollar, L Gossec, et al.
Annals of the Rheumatic Diseases|August 12, 2006
Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective studyS Guignard, L Gossec, C Salliot, et al.
Clinical and Experimental Rheumatology|July 17, 2007
Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockersA Ruyssen-Witrand, L Gossec, C Salliot, et al.
Annals of the Rheumatic Diseases|January 19, 2011
Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohortM Soubrier, C Lukas, J Sibilia, et al.
Clinical and Experimental Rheumatology|April 8, 2011
Psychometric properties of the OARSI/OMERACT osteoarthritis pain and functional impairment scales: ICOAP, KOOS-PS and HOOS-PSA Ruyssen-Witrand, C J Fernandez-Lopez, L Gossec, et al.
Osteoarthritis and Cartilage|March 15, 2011
Validity and responsiveness of radiographic joint space width metric measurement in hip osteoarthritis: a systematic reviewD Chu Miow Lin, W M Reichmann, L Gossec, et al.
Annals of the Rheumatic Diseases|April 12, 2011
Treating rheumatoid arthritis to target: the patient version of the international recommendationsM P T de Wit, J S Smolen, L Gossec, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2015
Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experienceN Betteridge, W-H Boehncke, C Bundy, et al.
Clinical and Experimental Rheumatology|June 10, 2006
Leflunomide in rheumatoid arthritis in daily practice: treatment discontinuation rates in comparison with other DMARDsI Bettembourg-Brault, L Gossec, T Pham, et al.
Rheumatology (Oxford, England)|August 2, 2006
Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patientsC Salliot, L Gossec, A Ruyssen-Witrand, et al.
La Revue De Medecine Interne|December 4, 2012
[Whipple disease revealed by anti-TNFα therapy]L Sparsa, F Fenollar, L Gossec, et al.
Annals of the Rheumatic Diseases|August 12, 2006
Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective studyS Guignard, L Gossec, C Salliot, et al.
Clinical and Experimental Rheumatology|July 17, 2007
Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockersA Ruyssen-Witrand, L Gossec, C Salliot, et al.
Annals of the Rheumatic Diseases|January 19, 2011
Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohortM Soubrier, C Lukas, J Sibilia, et al.
Clinical and Experimental Rheumatology|April 8, 2011
Psychometric properties of the OARSI/OMERACT osteoarthritis pain and functional impairment scales: ICOAP, KOOS-PS and HOOS-PSA Ruyssen-Witrand, C J Fernandez-Lopez, L Gossec, et al.
Osteoarthritis and Cartilage|March 15, 2011
Validity and responsiveness of radiographic joint space width metric measurement in hip osteoarthritis: a systematic reviewD Chu Miow Lin, W M Reichmann, L Gossec, et al.
Annals of the Rheumatic Diseases|April 12, 2011
Treating rheumatoid arthritis to target: the patient version of the international recommendationsM P T de Wit, J S Smolen, L Gossec, et al.
Pageof 7